In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Galapagos enters new collaboration in autoimmune discovery research
Galapagos and Merck Serono enter new collaboration agreements
Galapagos enters into oncology target discovery collaboration with Janssen Pharmaceutica
GALAPAGOS ENTERS INTO DISCOVERY COLLABORATION WITH IDENIX FOR INFECTIOUS DISEASE PROGRAMS
Galapagos receives milestone payment in antibody collaboration
Galapagos extends drug discovery collaboration with Amgen into 2010
Galapagos enters strategic alliance in diabetes and obesity with Merck & Co., Inc.
Galapagos enters strategic alliance in inflammatory diseases with Merck & Co., Inc.
Dako enters new collaboration on targeted therapies
Ambit and Roche announce collaboration and venture financing